Furthermore, XPO5 dephosphorylation favoured the distribution of XPO5 into the cytoplasm, leading to hepatocellular carcinoma inhibition in vitro and in vivo [204]. This evidence concerns the gene XPO5 and hepatocellular carcinoma.